Previous studies identified that IGF2BP1 promoted tumor progression, which contributed to the malignant phenotypes of tumor cells, and multiple types of human cancers showed poor OS and metastasis when IGF2BP1 was upregulated [27, 30, 31]. Here, IGF2BP1 is linked to neoplasm.